Bridge Medicines
company
About
Bridge Medicines is a drug discovery company
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Industries
- Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Bridge Medicines is a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Bridge Medicines is a groundbreaking initiative that completes an unbroken, fully funded and professionally staffed path from concept to drug candidate, to develop efficiently and quickly innovative therapeutics for the treatment of human diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$10M
Bridge Medicines has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Nov 13, 2020 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 13, 2020 | Series Unknown | $10M | 1 | — | — | Detail |
| Oct 31, 2016 | Series Unknown | — | 1 |
Takeda
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Bridge Medicines is funded by 1 investors.
Takeda
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Takeda
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
